论文部分内容阅读
目的:研究中西医结合治疗配合护理在心脏瓣膜病患者围术期中的临床疗效。方法:将我院2014年5月-2015年11月收治的60例预行手术治疗的心脏瓣膜病患者随机分为对照组和治疗组各30例,对照组采用华法林纳片治疗,同时采用中西医联合治疗;治疗组采用华法林纳片联合益气通络汤治疗,并实施中西医护理干预。比较两组患者手术前后中医症候积分、生活质量及并发症发生率。结果:术后对照组患者中医症候积分高于治疗组,并发症发生率(26.7%)高于治疗组(6.7%),差异均有统计学意义(P<0.05);对照组患者生活质量评分低于治疗组,差异有统计学意义(P<0.05)。结论:围术期心脏瓣膜病患者采用中西医结合治疗配合护理效果显著,能有效改善患者生活质量。
Objective: To study the clinical effect of combined traditional Chinese and western medicine in the treatment of patients with valvular heart disease during perioperative period. Methods: Sixty patients with valvular heart disease undergoing surgery in our hospital from May 2014 to November 2015 were randomly divided into control group (30 cases) and treatment group (30 cases). The control group was treated with warfarin sodium tablets Combination of Chinese and Western medicine treatment; treatment group with warfarin tablets combined with qi Tong Tongluo treatment, and the implementation of Chinese and Western nursing intervention. The TCM symptom scores, quality of life and complication rates before and after surgery were compared between the two groups. Results: The postoperative TCM symptom score of the control group was higher than that of the treatment group, the complication rate (26.7%) was higher than that of the treatment group (6.7%), the differences were statistically significant (P <0.05) Lower than the treatment group, the difference was statistically significant (P <0.05). Conclusion: Perioperative patients with valvular heart disease combined with traditional Chinese and western medicine treatment with a significant effect, can effectively improve the quality of life of patients.